DISCOVER OUR PORTFOLIO FOR
SEXUALLY TRANSMITTED INFECTIONS
DISCOVER OUR PORTFOLIO FOR
SEXUALLY TRANSMITTED INFECTIONS
INTRODUCING MORE SOLUTIONS FOR INTEGRATED TESTING OF HIV, VIRAL HEPATITIS AND STIs.
Abbott recently introduced new rapid tests that address the latest recommendations by the ECDC1 and the EACS2 for integrated testing of HIV, viral Hepatitis and STIs.
In line with the actions to implement and intensify testing programmes in Europe, Abbott’s solutions are designed to aid in the earliest diagnosis for a fast linkage to care, with world class performance and a drop of blood.
INTRODUCING MORE SOLUTIONS FOR INTEGRATED TESTING OF HIV, VIRAL HEPATITIS AND STIs.
Abbott recently introduced new rapid tests that address the latest recommendations by the ECDC1 and the EACS2 for integrated testing of HIV, viral Hepatitis and STIs.
In line with the actions to implement and intensify testing programmes in Europe, Abbott’s solutions are designed to aid in the earliest diagnosis for a fast linkage to care, with world class performance and a drop of blood.
DETERMINE™ HIV ULTRA
Rapid and Accurate Detection of More Acute HIV Infections.
The 4th generation Determine™ HIV Ultra test enables increased case finding at a time when individuals are highly infectious. Identifying HIV-positive patients early facilitates fast and appropriate linkage to care, and helps to prevent further transmission of the disease.
DETERMINE™ HIV ULTRA
Rapid and Accurate Detection of More Acute HIV Infections.
The 4th generation Determine™ HIV Ultra test enables increased case finding at a time when individuals are highly infectious. Identifying HIV-positive patients early facilitates fast and appropriate linkage to care, and helps to prevent further transmission of the disease.
DETERMINE™ HBsAg 2
The world‘s most sensitive rapid diagnostic test for detection of hepatitis B surface antigen.3,4,5
Determine™ HBsAg 2, with an analytical sensitivity of just 0.1 IU/mL, is a highly sensitive, easy to use rapid lateral flow test that enables quick, accurate identification of HBsAg-positive patients earlier.
DETERMINE™ HBsAg 2
The world‘s most sensitive rapid diagnostic test for detection of hepatitis B surface antigen.3,4,5
Determine™ HBsAg 2, with an analytical sensitivity of just 0.1 IU/mL, is a highly sensitive, easy to use rapid lateral flow test that enables quick, accurate identification of HBsAg-positive patients earlier.
SD BIOLINE HCV
Hepatitis C Virus Test.
The SD BIOLINE HCV test is a highly accurate immunochromatographic rapid test for the qualitative detection of antibodies specific to HCV in human serum, plasma or whole blood.
DETERMINE™ SYPHILIS TP
Determine™ Syphilis TP is an in vitro, visually read, qualitative immunoassay used to detect antibodies to Treponema pallidum in human serum, plasma, and whole blood.
DETERMINE™ SYPHILIS TP
Determine™ Syphilis TP is an in vitro, visually read, qualitative immunoassay used to detect antibodies to Treponema pallidum in human serum, plasma, and whole blood.
©2021 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non US Citizens. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. Webcode 1161-01
References
1. ECDC_Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA, 2018
2. EACS Guidelines 9.1_2018
3. Downing RG., Forssten C., Kabbale P., Newton R., Robins T., Tamanoue Y. (2019, February). Determine™ HBsAg 2: A novel rapid test for the detection of hepatitis B virus infection. Poster session presented at: 28th Conference of Asian Pacific Association for the Study of the Liver; 2019 February 20-24; Manila, Philippines; based on package inserts or other company-produced material in public domain.
4. World Health Organisation. WHO performance evaluation acceptance criteria for HBsAg In vitro diagnostics in the context of WHO prequalification. Available at: http://www.who.int/diagnostics_laboratory/evaluations/hepb/161125_who_performance_criteria_hbsag_ivd.pdf?ua=1. Accessed 29 January 2019.
5. Amini A, Varsaneux O, Kelly H et al. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect Dis 2017; 17(Suppl 1):698-716.
©2021 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non US Citizens. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. Webcode 1161-01
References
1. ECDC_Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA, 2018
2. EACS Guidelines 9.1_2018
3. Downing RG., Forssten C., Kabbale P., Newton R., Robins T., Tamanoue Y. (2019, February). Determine™ HBsAg 2: A novel rapid test for the detection of hepatitis B virus infection. Poster session presented at: 28th Conference of Asian Pacific Association for the Study of the Liver; 2019 February 20-24; Manila, Philippines; based on package inserts or other company-produced material in public domain.
4. World Health Organisation. WHO performance evaluation acceptance criteria for HBsAg In vitro diagnostics in the context of WHO prequalification. Available at: http://www.who.int/diagnostics_laboratory/evaluations/hepb/161125_who_performance_criteria_hbsag_ivd.pdf?ua=1. Accessed 29 January 2019.
5. Amini A, Varsaneux O, Kelly H et al. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect Dis 2017; 17(Suppl 1):698-716.